Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Nelson

Showing results (431-440 of 521) with videos related to

Pageof 53
Sort By:
Molecular Biosystems|July 1, 2016
Systems level analysis of the Chlamydomonas reinhardtii metabolic network reveals variability in evolutionary co-conservationAmphun Chaiboonchoe, Lila Ghamsari, Bushra Dohai, et al.
Scientific Data|May 22, 2025
A near telomere-to-telomere phased reference assembly for the male mountain gorillaDavid R Nelson, Richard Muvunyi, Khaled M Hazzouri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2017
A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular CarcinomaQunfeng Wu, Liya Pi, Thu Le Trinh, et al.
Journal of Hepatology|September 15, 2014
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGETStuart C Gordon, Andrew J Muir, Joseph K Lim, et al.
Journal of Hepatology|November 28, 2012
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trialMaribel Rodriguez-Torres, Eric Lawitz, Kris V Kowdley, et al.
The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.
Molecular Plant|April 13, 2024
Macroalgal deep genomics illuminate multiple paths to aquatic, photosynthetic multicellularityDavid R Nelson, Alexandra Mystikou, Ashish Jaiswal, et al.
Elife|June 18, 2017
The genome and phenome of the green alga <i>Chloroidium sp.</i> UTEX 3007 reveal adaptive traits for desert acclimatizationDavid R Nelson, Basel Khraiwesh, Weiqi Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)Steven M Opal, Gary E Garber, Steven P LaRosa, et al.
Pageof 53

Showing results (431-440 of 521) with videos related to

Sort By:
Pageof 53
Molecular Biosystems|July 1, 2016
Systems level analysis of the Chlamydomonas reinhardtii metabolic network reveals variability in evolutionary co-conservationAmphun Chaiboonchoe, Lila Ghamsari, Bushra Dohai, et al.
Scientific Data|May 22, 2025
A near telomere-to-telomere phased reference assembly for the male mountain gorillaDavid R Nelson, Richard Muvunyi, Khaled M Hazzouri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2017
A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular CarcinomaQunfeng Wu, Liya Pi, Thu Le Trinh, et al.
Journal of Hepatology|September 15, 2014
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGETStuart C Gordon, Andrew J Muir, Joseph K Lim, et al.
Journal of Hepatology|November 28, 2012
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trialMaribel Rodriguez-Torres, Eric Lawitz, Kris V Kowdley, et al.
The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.
Molecular Plant|April 13, 2024
Macroalgal deep genomics illuminate multiple paths to aquatic, photosynthetic multicellularityDavid R Nelson, Alexandra Mystikou, Ashish Jaiswal, et al.
Elife|June 18, 2017
The genome and phenome of the green alga <i>Chloroidium sp.</i> UTEX 3007 reveal adaptive traits for desert acclimatizationDavid R Nelson, Basel Khraiwesh, Weiqi Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)Steven M Opal, Gary E Garber, Steven P LaRosa, et al.
Pageof 53